Bleo-S Ointment 5 mg/g (ブレオS軟膏5mg/g)

국가: 일본

언어: 영어

출처: すりの適正使用協議会 RAD-AR Council, Japan

유효 성분:

Bleomycin sulfate

제공처:

NIPPON KAYAKU

INN (국제 이름):

Bleomycin sulfate

약제 형태:

clear to pale yellow, translucent ointment

제품 요약:

Print on wrapping: ブレオS軟膏5 mg/g, 5 mg（力価）/g, 5g

환자 정보 전단

Drug Information Sheet("Kusuri-no-Shiori")
External
Revised: 07/2023
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
BLEO-S OINTMENT 5 MG/G
ACTIVE INGREDIENT:
Bleomycin sulfate
DOSAGE FORM:
clear to pale yellow, translucent ointment
IMPRINT OR PRINT ON WRAPPING:
ブレオ S 軟膏 5 mg/g, 5 mg（力価）/g, 5g
EFFECTS OF THIS MEDICINE
This medicine suppresses proliferation of tumor cells by breaking DNA
strands in cells and
inhibiting DNA synthesis.
It is usually used in the treatment of skin cancer.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
・If you have or have a history of lung disorder.
・If you have heart disease, renal or liver disorder.
・If you receive radiation therapy to chest and its periphery.
・If you have varicella (chickenpox).
・If you have received bleomycin/peplomycin before.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・In general, apply 1 to 2.5 g (5 to 12.5 mg potency of the active
ingredient) per 100 cm
2
[10
cm x10 cm] of an affected site with the occlusive dressing technique [
ODT, a technique in
which the ointment is applied to the affected site,